A novel autoantibody, glial fibrillary acidic protein (GFAP)-IgG, has recently been associated with cases of meningoencephalomyelitis. This entity is still being unraveled. Very few pediatric patients have been identified; thus, the clinical, biological and imaging phenotype remains to be defined. Herein we describe the clinical course of a 6-year-old patient initially suspected to have a demyelinating disease but ultimately diagnosed with GFAP-IgG positive autoimmune meningoencephalomyelitis. We also provide a review of the literature regarding this novel entity.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.msard.2018.12.008 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!